Ovid Therapeutics宣布,任命在医学研究与生物技术领域享有盛誉的创新者安娜·格雷卡博士加入其董事会。格雷卡博士身兼医师与科学家双重身份,她的加入将为公司董事会带来深厚的学术背景与前沿的生物科技产业洞察。
Ovid Therapeutics宣布,任命在医学研究与生物技术领域享有盛誉的创新者安娜·格雷卡博士加入其董事会。格雷卡博士身兼医师与科学家双重身份,她的加入将为公司董事会带来深厚的学术背景与前沿的生物科技产业洞察。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.